Kalos Management, Inc. Pfizer Inc Transaction History

Kalos Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $7,878 - $10,256	200 New	200 $8,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $124,933 - $148,131	-2,685 Reduced 30.33%	6,167 $322,000
Q1 2022 Jun 21, 2022	SELL	$45.75 - $56.69 $377,574 - $467,862	-8,253 Reduced 48.25%	8,852 $458,000
Q4 2021 Feb 03, 2022	BUY	$41.32 - $61.25 $27,147 - $40,241	657 Added 3.99%	17,105 $813,000
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $291,823 - $374,872	7,435 Added 82.49%	16,448 $782,000
Q2 2021 Aug 11, 2021	SELL	$35.91 - $40.68 $308,969 - $350,010	-8,604 Reduced 48.84%	9,013 $397,000
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $280,478 - $316,323	8,375 Added 90.62%	17,617 $685,000
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $1,372 - $1,744	41 Added 0.45%	9,242 $331,000
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $94,424 - $110,781	2,974 Added 47.76%	9,201 $347,000
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $187,557 - $227,534	6,227 New	6,227 $223,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Kalos Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kalos Management, Inc. with notifications on news.